Stocks & AI: what moved, and why Inspired by zlio.com

RPRX Royalty Pharma plc

Nasdaq · Healthcare

RPRX chart by TradingView

Tue, Nov 10 1.0× volume +1.0%
Mon, Nov 9 1.1× volume +2.2%
Fri, Nov 6 1.5× volume -0.4%
Thu, Nov 5 1.6× volume +0.0%
Wed, Nov 4 1.2× volume +1.7%
Tue, Nov 3 1.0× volume -0.2%
Mon, Nov 2 0.9× volume -1.0%

Top holding of RKLC.TO 10.6%, CCGP.TO 9.3%, CCUL.TO 8.5%, CGDV.TO 6.3%, IHE 4.9%, FNDA 0.4%

News this week

  1. Royalty Pharma raises 2026 portfolio receipts guidance to $3.5B-$3.55B while outlining $1.7B-plus future peak royalties
    RPRX +1.0%2 sourcesSeeking Alpha ·